39ArZ3KQU
39ArZ3KQU 39ArZ3KQU
F. Lopez (2000), «Better approaches to finding the needle in a haystack: optimizing proteomeM.through automation.»Electrophoresis, vol.21, p.1082.analysisKellner, F. Lottspeich and R. Meyer (1999) Microcharacterization ofProteins, 2 nd , Wiley VCR.R.3-527-30084-8.ISBNLottspeich (1999). «Proteome Analysis: A Pathway to the Functional Analysis of Proteins.» AngewandteF.Chemie International Edition, vol. 38, p. 2476.Hansson, C. Oostenbrink, W. van Gunsteren (2002), «Molecular dynamics simulations.»CurrentT.Opinion in Structural Biology, vol. 12, p. 190.N. Kinch and N. V.Grishin (2002). «Evolution of protein structures and functions.»CurrentL.in Structural Biology, vol. 12, p.400.OpinionNorin and M Sundstrom (2002). «Structural proteomics: developments in structure-to-functionM.Trends inBiotechnology, vol. 20, p. 79.predictions.»Saven (2002), «Combinatorial protein design.» Current Opinion in Structural Biology, vol.12,p.J.453.Reiss (2001). «Drug discovery of the future: the implications of the human genome project.»T.in Biotechnology, vol. 19, p. 496.TrendsRamanathan and D. Davison (2001),Pharmaceutical Bioiriformatics and Drug Discovery in Biotechnology.C.2 nd Edition, 123.Vol. 5b. C Sensen (ed.). VCH-Wiley, ISBN 3527-28328-5.N. Kyranos, H. Cai, D Wei, W. K. Goetzinger (2001), «High-throughput high-performance liquidJ.chromatography/mass spectrometry for modern drug discovery.» Current Opinion inM. Lawn and L. A. Lasky (2000), «Phannaceutical biotechnology: The genomes are just the beginning.»R.Current Opinion in Structural Biology, vol. 11, p. 579.Gregersen (1995),Biomedicinal Product Development in Biotechnology 2 nd Edition, 213. Vol. 12,J.Brauer (ed.). VCRWiley, ISBN 3-527-28322-6D.Rice (2001), Bioinformatics: Tools for DNA Technologies in Biotechnology 2 nd Edition, 61.P.5b, C. Sensen (ed.). VCHWiley, ISBN 3-527-28328-5.Vol.Wishart (2001),Bioinformatics: Tools for Protein Technologies in Biotechnology 2 nd Edition,D.Vol. 5b, C. Sensen (ed.). VCH Wiley, ISBN 3-527-28328-5.325.Zdobnov, R. Lopez, R. Apweiler and T. Etzold (2001), Bioinformatics: Using the Molecular.E.Data in Biotechnology 2 nd Edition, 281. Vol. 5b, C. Sensen (ed.). VCHWiley, ISBNBiologyCygler, A. Matte and J. Schrag (2001),Bioinformatics: Structure Information in BiotechnologyM. nd Edition, 345. Vol. 5b, C. Sensen (ed.); VCR-Wiley, ISBN 3-52728328-5.2Poetzsch (1995), Databases in Biotechnology in Biotechnology 2 nd Edition, 323. Vol. 12, D.E.(ed.). VCH-Wiley, ISBN 3-527-28322-6.BrauerDrug screening?*hO}G?z
Kramer and G. Sprenger (1993) Metabolism in Biotechnology Second, Completely Revised Edition,R.50. Vol. 1, H. Sahm (ed.). VCR Verlagsgesellschaft, ISBN 3-527-28337-4Christensen and J. Nielsen (2000), «Metabolic network analysis: A powerful tool in metabolicB.Advances in Biochemical Engineering/Biotechnology, vol. 66, p. 209.engineering.»Fotheringham (1999), Engineering Microbial Pathways for Amino Acid Production in Biotechnology,I.2 nd Edition, 313, Vol. 8a, D. Kelly (ed.). VCH-Wiley, ISBN 3-527-30104-6.N. Stephanopoulos, A. A. Aristidou, J, Nielsen (1998), Metabolic Engineering -Principles andG.Academic Press, ISBN 0-12-666260-6.Methodologies,Hansen and M. C. Kielland-Brandt (1996), «Modification of biochemical pathways in industrialJ.Journal of Biotechnology, vol. 49, p. 1.yeasts.»Sahm (1993). Metabolic Design in Biotechnology Second, Completely Revised Edition, 189.H.1, H. Sahm (ed.). VCH Verlagsgesellschaft, ISBN 3-52728337-4.Vol.M. Loew, J. C. Schaff (2001), «The Virtual Cell: a software environment for computational cellL.Trends inBiotechnology, vol. 19, p. 401.biology.»L. Simpson, G. S. Sayler, J.T.Fleming, B. Applegate (2001), «Whole-cell biocomputing.»M.inBiotechnology, vol. 19, p. 317.TrendsDroge, A. PuÈ hler and W. Selbitschka (1998), «Horizontal gene transfer as a biosafety issue: aM.phenomenon of public concern.» Journal of Biotechnology, vol. 64, p. 75.naturalBrauer, M. Broker, C. Kellermann and E. Winnacker (1995),Biosafety in rDNA Research andD.in Biotechnology 2 nd Edition, 63. Vol. 12, D. Brauer (ed.). VCH-Wiley, ISBN 3-ProductionMedley and S. McCammon (1995). Strategic Regulations for Safe Development of TransgenicT.in Biotechnology 2 nd Edition, 197. Vol. 12, D. Brauer (ed.). VCH Wiley, ISBN 3-527-PlantsSimon and W Frommer (1993) Safety Aspects in Biotechnology in Biotechnology Second, CompletelyR.Revised Edition. 835. Vol. 2, A. PuÈ hler (ed.). VCH Verlagsgesellschaft, ISBN 3-527-Hasskarl, R. Kretzschmar, K-J. Hahn and M. Zahn (1991) Pharmaceuticals, General SurveyH.Development in Ullmann's Encyclopedia of Industrial Chemistry 5 th edition A19, 273.and^*}G--H;tAS:GMetabolismG. Michal (1999), Biochemkal Pathways, Spelctrum Akademischer Verlag. ISBN 386025-239-9.Metabolic engineering?+]*}G?SO"%yG~zfSystem biology~d"yG )9+F(y(+
- Page 377 and 378: d(w*;i #+zD*EoxoglutarateJGQ9@(zi(T
- Page 379 and 380: f($OyG?*Q(qS(qyGphospholipidsIQqTqy
- Page 381 and 382: ^>x+"+q*Q=yGprephenic acidJGQ+}+y(=
- Page 383 and 384: MC o Q= p Gredox reactionsIOyRBG J;
- Page 385 and 386: shigellosisG?
- Page 387 and 388: ?+fP@G 9*;BGstem cellsRvGQ|?+iGQpst
- Page 389 and 390: thrombolytic agents?y9AG IQDMzy {|G
- Page 391 and 392: ?+ppvariable numbers of tendem repe
- Page 394 and 395: Rehm, G. Reed, A PuÈ hler, P. Stad
- Page 396 and 397: Ross, S. Morgan, C. Rill (2002). «
- Page 398 and 399: G. Peters-Wendisch, B. Schiel. V. F
- Page 400 and 401: polyetherGlycopeptide,nucleoside an
- Page 402 and 403: van Kranenburg, I.C. Boels, M.Kleer
- Page 404 and 405: S. Jackman, J. Stratford (2000).Hal
- Page 406 and 407: R. Whistler andJ. Daniel (1997) Sta
- Page 408 and 409: Beilen and Z.Li (2002), «Enzyme te
- Page 410 and 411: kl (1999). Modeling of Biogas React
- Page 412 and 413: Shoelson (1995).Insulin and Other A
- Page 414 and 415: Wetzel (1999) Medical Applications
- Page 416 and 417: Wolf, V. Zakhartchenko and G. Brem
- Page 418 and 419: +CGQh :9 kJ. Mol, E. Cornish, J. Ma
- Page 420 and 421: Crueger (1993). Mutagenesis in Biot
- Page 422 and 423: Bardouille (2001). Maintenance of C
- Page 424 and 425: GoÈ tz (1993) Structure and Functi
- Page 426 and 427: Green (2001), Genomics and Human Di
- Page 430 and 431: J. Dale (1999), «Public reactions
- Page 432 and 433: SdvvvvvS6vvCG?\9}G?+"+|}G?$Q9wyG:A9
- Page 434 and 435: J9}*R!C|W"AyGv:R9@9D"+TyG238*vR !vC
- Page 436 and 437: ~*QMAyG:,F9+ZMAyG:L9FRy9 h+"Z@:f(}+
- Page 438 and 439: ^>vGyvjv(zv9@v|vx+vv:L,40,56,78,138
- Page 440 and 441: e9gayG:Q}MCG24?pOV d(_QZAG?:9"yG#|O
- Page 442 and 443: ,196,198,204,206,208,210,212,214,22
- Page 444 and 445: ?@9gCG?+F(y(+=yG:?
- Page 446: ~ ]v gP$v yvG zv Tv ? zv Tv Q @v Fv
F. Lopez (2000), «Better approaches to finding the needle in a haystack: optimizing proteomeM.through automation.»Electrophoresis, vol.21, p.1082.analysisKellner, F. Lottspeich and R. Meyer (1999) Microcharacterization ofProteins, 2 nd , Wiley VCR.R.3-527-30084-8.ISBNLottspeich (1999). «Proteome Analysis: A Pathway to the Functional Analysis of Proteins.» AngewandteF.Chemie International Edition, vol. 38, p. 2476.Hansson, C. Oostenbrink, W. van Gunsteren (2002), «Molecular dynamics simulations.»CurrentT.Opinion in Structural Biology, vol. 12, p. 190.N. Kinch and N. V.Grishin (2002). «Evolution of protein structures and functions.»CurrentL.in Structural Biology, vol. 12, p.400.OpinionNorin and M Sundstrom (2002). «Structural proteomics: developments in structure-to-functionM.Trends inBiotechnology, vol. 20, p. 79.predictions.»Saven (2002), «Combinatorial protein design.» Current Opinion in Structural Biology, vol.12,p.J.453.Reiss (2001). «Drug discovery of the future: the implications of the human genome project.»T.in Biotechnology, vol. 19, p. 496.TrendsRamanathan and D. Davison (2001),Pharmaceutical Bioiriformatics and Drug Discovery in Biotechnology.C.2 nd Edition, 123.Vol. 5b. C Sensen (ed.). VCH-Wiley, ISBN 3527-28328-5.N. Kyranos, H. Cai, D Wei, W. K. Goetzinger (2001), «High-throughput high-performance liquidJ.chromatography/mass spectrometry for modern drug discovery.» Current Opinion inM. Lawn and L. A. Lasky (2000), «Phannaceutical biotechnology: The genomes are just the beginning.»R.Current Opinion in Structural Biology, vol. 11, p. 579.Gregersen (1995),Biomedicinal Product Development in Biotechnology 2 nd Edition, 213. Vol. 12,J.Brauer (ed.). VCRWiley, ISBN 3-527-28322-6D.Rice (2001), Bioinformatics: Tools for DNA Technologies in Biotechnology 2 nd Edition, 61.P.5b, C. Sensen (ed.). VCHWiley, ISBN 3-527-28328-5.Vol.Wishart (2001),Bioinformatics: Tools for Protein Technologies in Biotechnology 2 nd Edition,D.Vol. 5b, C. Sensen (ed.). VCH Wiley, ISBN 3-527-28328-5.325.Zdobnov, R. Lopez, R. Apweiler and T. Etzold (2001), Bioinformatics: Using the Molecular.E.Data in Biotechnology 2 nd Edition, 281. Vol. 5b, C. Sensen (ed.). VCHWiley, ISBNBiologyCygler, A. Matte and J. Schrag (2001),Bioinformatics: Structure Information in BiotechnologyM. nd Edition, 345. Vol. 5b, C. Sensen (ed.); VCR-Wiley, ISBN 3-52728328-5.2Poetzsch (1995), Databases in Biotechnology in Biotechnology 2 nd Edition, 323. Vol. 12, D.E.(ed.). VCH-Wiley, ISBN 3-527-28322-6.BrauerDrug screening?*hO}G?z
Change language